Atlas Trials

Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100

Clinical trial NCT01135680 · COMPLETED

Trial details

NCT number
NCT01135680
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug Toxicity
Start date
2010-05-01
Primary completion
2010-09-01
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.